| Literature DB >> 31201505 |
Jieying Wang1,2, Tetsuo Kondo3, Tadao Nakazawa3, Naoki Oishi3, Kunio Mochizuki3, Ryohei Katoh3.
Abstract
Nuclear membrane proteins reportedly play important roles in maintaining nuclear structures and coordinating cell activities. Studying profiles of nuclear membrane proteins may help us evaluate the biological and/or clinical nature of malignant tumors. Using immunohistochemistry with antibodies for emerin, lamin A/C, lamin B, and LAP2, we examined 105 lung cancer tissues from 33 small cell lung carcinomas (SCLCs) and 72 non-SCLCs (34 adenocarcinomas, 30 squamous cell carcinomas, and 8 large cell carcinomas). Emerin had negative or local/weak positivity in 79% of SCLCs and 1% of non-SCLCs, and lamin A/C had similar positivity in 91% of SCLCs and 3% of non-SCLCs. LAP2's expression was similar between SCLCs and non-SCLCs. RT-PCR analyses for these four nuclear membrane proteins over 7 cell lines showed that mRNA of emerin and lamin A/C were distinctly downregulated in the SCLC cell lines, supporting the immunohistochemical results. In conclusion, we suggest that downregulation of the nuclear membrane proteins emerin and lamin A/C is characteristic of SCLC cells, and this constitutional abnormality of the nuclear membrane may be related to the biological and/or clinical nature of SCLC. In addition, knowing the nuclear protein profile in SCLC cells may contribute to our understanding of nuclear fragility known as the crush artifact in pulmonary biopsy specimens.Entities:
Keywords: Immunohistochemistry; Lung carcinoma; Nuclear membrane proteins; Polymerase chain reaction (PCR)
Mesh:
Substances:
Year: 2019 PMID: 31201505 DOI: 10.1007/s00428-019-02597-7
Source DB: PubMed Journal: Virchows Arch ISSN: 0945-6317 Impact factor: 4.064